HSCS (HeartSciences) Interest Expense: $-0.71 Mil (TTM As of Jan. 2026)

What is HeartSciences Interest Expense?

HeartSciences HSCS +1.10% 42 Interest Expense is $-0.71 Mil as of Jan. 2026. GuruFocus rates HSCS with a GF Score™ of 42/100 and a GF Value™ of $2.61 (Fairly Valued). The stock has 7 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. HeartSciences's interest expense for the three months ended in Jan. 2026 was $ -0.06 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jan. 2026 was $-0.71 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. HeartSciences's Operating Income for the three months ended in Jan. 2026 was $ -1.93 Mil. HeartSciences's Interest Expense for the three months ended in Jan. 2026 was $ -0.06 Mil. HeartSciences did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

HeartSciences (NAS:HSCS) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

HeartSciences's Interest Expense for the three months ended in Jan. 2026 was $-0.06 Mil. Its Operating Income for the three months ended in Jan. 2026 was $-1.93 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jan. 2026 was $0.63 Mil.

HeartSciences's Interest Coverage for the quarter that ended in Jan. 2026 is calculated as

HeartSciences did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

HeartSciences Interest Expense Historical Data

* Premium members only.

The historical data trend for HeartSciences's Interest Expense can be seen below:

HeartSciences Interest Expense Chart

HeartSciences Annual Data

Trend

Apr20

Apr21

Apr22

Apr23

Apr24

Apr25

Interest Expense

Get a 7-Day Free Trial

-0.13

-0.37

-0.24

-0.35

-0.50

HeartSciences Quarterly Data
	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25	Apr25	Jul25	Oct25	Jan26
Interest Expense	Get a 7-Day Free Trial															-0.18	-0.18	-0.18	-0.28	-0.06

42GF Score

HeartSciences Inc HSCS

Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

HeartSciences Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.71 Mil.

Frequently Asked Questions Learn more about Interest Expense →

What does a Interest Expense of $-0.71 Mil mean?

HeartSciences (HSCS) has a Interest Expense of $-0.71 Mil as of Jan. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on HeartSciences and its competitors.

Is HeartSciences' Interest Expense too high?

HeartSciences' current Interest Expense is $-0.71 Mil. Overall, HeartSciences has a GF Score™ of 42/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does HeartSciences' Interest Expense compare to CSDX and CODX?

HeartSciences' Interest Expense of $-0.71 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Interest Expense for a Medical Devices & Instruments company?

A good Interest Expense depends on the Medical Devices & Instruments industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Interest Expense mean?

A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on HeartSciences and its competitors. HeartSciences's current Interest Expense is $-0.71 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is HeartSciences stock overvalued right now?

Based on GuruFocus' analysis, HeartSciences (HSCS) is currently considered Fairly Valued. The stock's GF Value™ is $2.61, compared to a current price of $2.75 — trading 5.4% above its estimated fair value. The current Interest Expense is $-0.71 Mil. HeartSciences' overall GF Score™ is 42/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Interest Expense calculated?

Interest Expense is calculated from a company's financial statements. For HeartSciences (HSCS), the current Interest Expense is $-0.71 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HeartSciences (HSCS) Overvalued in 2026?

Based on GuruFocus' analysis, HeartSciences stock appears to be overvalued. The current stock price of $2.75 is trading 5.4% above its estimated GF Value™ of $2.61. GuruFocus considers HeartSciences to be Fairly Valued.

Key valuation signals for HSCS:

Interest Expense: $-0.71 Mil
GF Value™: $2.61 vs. price of $2.75 (5.4% above fair value)
GF Score™: 42/100 with 7 warning signs

No single metric tells the full story. See the HSCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

HeartSciences Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies CSDX CODX ALRTF NXL STME NVNO AIDX TRIB SINT VVOS ABT SYK MDT BSX EW XTER:SHL GEHC DXCM XAMS:PHIA SZSE:300760

Address 550 Reserve Street, Suite 360, Southlake, TX, USA, 76092

Website https://www.heartsciences.com

HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.

42GF Score

Get the complete analysis for HSCS

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.75

Price

$2.61

GF Value

View HSCS Analysis

See Interest Expense data for all stocks →